Efficacy and tolerability after 24weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV–HCV coinfected subjects
Titel:
Efficacy and tolerability after 24weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV–HCV coinfected subjects
Auteur:
Genebat, Miguel Vera, Francisco Hernández-Quero, José Domingo, Pere Guardiola, José M. Martínez-Madrid, Onofre Martínez, Lorena de la Llana, Francisco García Sánchez-Villegas, Jorge Álvarez, Hortensia Mariño, Ana Lluch, José F. Martínez-Pérez, María A. Marín, Jorge Ruiz-Mateos, Ezequiel Leal, Manuel